StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note released on Thursday morning. The firm issued a hold rating on the stock. Separately, Cantor Fitzgerald reiterated a neutral rating on shares of TherapeuticsMD in a report on Thursday, August 17th. Read Our Latest Stock Report on TXMD TherapeuticsMD Stock […]
StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a report released on Friday. The brokerage issued a hold rating on the stock. Separately, Cantor Fitzgerald reaffirmed a neutral rating on shares of TherapeuticsMD in a research report on Thursday, August 17th. View Our Latest Report on TXMD TherapeuticsMD Stock Performance Shares […]
StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note issued to investors on Monday. The brokerage issued a hold rating on the stock. Separately, Cantor Fitzgerald restated a neutral rating on shares of TherapeuticsMD in a research note on Thursday, August 17th. View Our Latest Research Report on TherapeuticsMD […]
StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note published on Tuesday morning. The brokerage issued a hold rating on the stock. Separately, Cantor Fitzgerald reissued a neutral rating on shares of TherapeuticsMD in a research report on Thursday, August 17th. Check Out Our Latest Research Report on TXMD […]
StockNews.com initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report released on Wednesday. The firm issued a hold rating on the stock. Separately, Cantor Fitzgerald reaffirmed a neutral rating on shares of TherapeuticsMD in a research note on Thursday, August 17th. Read Our Latest Stock Report on TXMD TherapeuticsMD Stock […]